Longevity Health Holdings, Inc. (NASDAQ:XAGE – Get Free Report)’s stock price was up 9.3% on Thursday . The company traded as high as $0.3390 and last traded at $0.3390. Approximately 22,276 shares changed hands during trading, an increase of 656% from the average daily volume of 2,948 shares. The stock had previously closed at $0.3102.
Longevity Health Trading Down 11.5%
The firm has a market capitalization of $534,600.00, a price-to-earnings ratio of -0.07 and a beta of 0.37. The stock’s 50 day moving average price is $0.34 and its two-hundred day moving average price is $0.36.
About Longevity Health
Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.
Recommended Stories
- Five stocks we like better than Longevity Health
- Costco’s Strong Quarter Still Leaves Investors With a Valuation Problem
- These 3 Software Stocks Are Buying Back Shares Hand Over Fist
- Gap Inc. Cuts Sales Outlook After Q1 Miss, Shares Drop 17%
- MongoDB’s AI Advantage Is Starting to Show Up in Results
Receive News & Ratings for Longevity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Longevity Health and related companies with MarketBeat.com's FREE daily email newsletter.
